Benefit of adjuvant chemotherapy for patients with stage IB non-small cell lung cancer: a systematic review and meta-analysis.

Wang, Xiaofan; Chen, Donglai; Wen, Junmiao; Mao, Yiming; Zhu, Xuejuan; Fan, Min; Chen, Yongbing

Wang, Xiaofan; Chen, Donglai; Wen, Junmiao; Mao, Yiming; Zhu, Xuejuan; Fan, Min; Chen, Yongbing.

Afiliación

Wang X; Department of Thoracic Surgery, the Second Affiliated Hospital of Soochow University, Suzhou, China.
Chen D; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, School of Medicine, Shanghai, China.
Wen J; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Mao Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhu X; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Fan M; Department of Surgery, Children's Hospital of Soochow University, Suzhou, China.
Chen Y; Department of Thoracic Surgery, the Second Affiliated Hospital of Soochow University, Suzhou, China.

Ann Transl Med ; 9(18): 1430, 2021 Sep.

Article en En | MEDLINE | ID: mdl-34733982

Palabras clave

Non-small cell lung cancer (NSCLC); adjuvant chemotherapy; meta-analysis; stage IB

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Ann Transl Med Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google